KK AIN HOLDINGS header image

KK AIN HOLDINGS

9627

Equity

ISIN JP3105250009 / Valor 961399

Tokyo Stock Exchange (2024-09-13)
JPY 5,072.00-1.88%

KK AIN HOLDINGS
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

KK AIN HOLDINGS is a company engaged in the management and investment of various business ventures and assets.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (14.08.2024):

Net Sales Growth

KK AIN HOLDINGS reported consolidated net sales of ¥399,824 million for the fiscal year ended April 2024, marking an 11.5% increase compared to the previous fiscal year. This growth reflects the company's successful strategies in expanding its market presence and improving sales performance across its various business segments.

Operating Profit Increase

The company achieved an operating profit of ¥20,432 million for the fiscal year ended April 2024, representing a significant 27.7% year-on-year increase. This improvement in operating profit is attributed to enhanced operational efficiencies and cost management initiatives implemented throughout the year.

Profit Attributable to Owners

KK AIN HOLDINGS recorded a profit attributable to owners of the parent amounting to ¥11,401 million for the fiscal year ended April 2024, which is a 23.5% increase from the previous year. This rise in profitability underscores the company's ability to generate higher returns for its shareholders.

Dividends

For the fiscal year ended April 2024, KK AIN HOLDINGS declared an annual dividend of ¥80.00 per share, up from ¥60.00 per share in the previous year. The total dividends paid amounted to ¥2,826 million, reflecting a dividend payout ratio of 24.6%, which demonstrates the company's commitment to returning value to its shareholders.

Future Outlook

Looking ahead to the fiscal year ending April 2025, KK AIN HOLDINGS forecasts consolidated net sales of ¥415,000 million, representing a 3.8% year-on-year increase. However, the company anticipates a decline in operating profit to ¥17,800 million, a 12.9% decrease, as it navigates potential economic uncertainties and market fluctuations.

Summarized from source with an LLMView Source

Key figures

15.5%1Y
-32.8%3Y
-17.8%5Y

Performance

34.9%1Y
33.4%3Y
32.8%5Y

Volatility

Market cap

1278 M

Market cap (USD)

Daily traded volume (Shares)

122,800

Daily traded volume (Shares)

1 day high/low

5176 / 5072

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

AstraZeneca PLC
AstraZeneca PLC AstraZeneca PLC Valor: 163523
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.98%USD 79.04
Boiron SA
Boiron SA Boiron SA Valor: 487646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.31%EUR 32.30
Calliditas Therapeutics AB
Calliditas Therapeutics AB Calliditas Therapeutics AB Valor: 42290712
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.10%SEK 206.40
OKYO Pharma Limited
OKYO Pharma Limited OKYO Pharma Limited Valor: 127195533
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.46%USD 1.04
Sanofi SA
Sanofi SA Sanofi SA Valor: 1447201
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.35%USD 57.33
Bausch Health Companies Inc
Bausch Health Companies Inc Bausch Health Companies Inc Valor: 42260834
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
10.76%USD 7.00
Biogen Inc
Biogen Inc Biogen Inc Valor: 1720684
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.02%USD 199.58
Illumina Inc
Illumina Inc Illumina Inc Valor: 1111080
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.26%USD 129.52
Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc Alnylam Pharmaceuticals Inc Valor: 1806798
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.92%USD 270.37
Align Technology Inc
Align Technology Inc Align Technology Inc Valor: 1159441
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.39%USD 249.56